Akero Therapeutics Inc Phase 2b SYMMETRY Data Presentation Transcript
Presentation
Oct 10, 2023 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Andrew Cheng
Akero Therapeutics, Inc. - President, CEO & Director
* Catriona Yale
Akero Therapeutics, Inc. - Executive VP & Chief Development Officer
* Timothy Rolph
Akero Therapeutics, Inc. - Co-Founder & Chief Scientific Officer
* William R. White
Akero Therapeutics, Inc. - Executive VP, CFO, Treasurer & Head of Corporate Development
=====================
Conference Call Participants
=====================
* Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst
* Liisa Ann Bayko
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst
* Michael Eric Ulz
Morgan Stanley, Research Division - Equity Analyst
* Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
=====================
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |